Jobs at CRISPR Therapeutics
Gene-editing pioneer (Nasdaq: CRSP) using CRISPR/Cas9 to develop therapies for blood disorders, oncology, and in vivo gene editing; co-developer of Casgevy. Headquartered in Zug, Switzerland with US operations in Boston, MA.